Why sleep is important for health: A psychoneuroimmunology perspective

Annual Review of Psychology

Volumn 66, Issue , 2015, Pages 143-172

  Irwin, Michael R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adaptive immunity; Cancer; Cardiovascular disease; Depression; Infectious disease; Inflammation; Innate immunity; Insomnia; Psychoneuroimmunology; Sleep; Sleep deprivation; Sleep restriction; Vaccine

Indexed keywords

COMPLICATION; ETIOLOGY; HUMAN; IMMUNE SYSTEM; INFLAMMATION; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOPHYSIOLOGY; SLEEP; SLEEP DISORDER;

COMPLICATIONS; ETIOLOGY; HUMANS; IMMUNE SYSTEM; INFLAMMATION; PHYSIOLOGY; PHYSIOPATHOLOGY; PSYCHONEUROIMMUNOLOGY; SLEEP; SLEEP DISORDERS;

EID: 84964255430     PISSN: 00664308     EISSN: 15452085     Source Type: Book Series    
DOI: 10.1146/annurev-psych-010213-115205     Document Type: Article

References (197)

1. Abedelmalek S, Chtourou H, Aloui A, Aouichaoui C, Souissi N, Tabka Z. 2013. Effect of time of day and partial sleep deprivation on plasma concentrations of IL-6 during a short-term maximal performance. Eur. J. Appl. Physiol. 113:241-48
2. Afshar R, Emany A, Saremi A, Shavandi N, Sanavi S. 2011. Effects of intradialytic aerobic training on sleep quality in hemodialysis patients. Iran J. Kidney Dis. 5:119-23
3. Am. Psychiatr. Assoc. 2013. Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: Am. Psychiatr. Publ. 5th ed.
4. Ancoli-Israel S, Cole R, Alessi C, Chambers M, Moorcroft W, Pollak CP. 2003. The role of actigraphy in the study of sleep and circadian rhythms. Sleep 26:342-92
5. Andreakos E, Foxwell B, Feldmann M. 2004. Is targeting Toll-like receptors and their signaling pathway a useful therapeutic approach to modulating cytokine-driven inflammation? Immunol. Rev. 202:250-65
6. Ayas NT, White DP, Manson JE, Stampfer MJ, Speizer FE, et al. 2003. A prospective study of sleep duration and coronary heart disease in women. Arch. Intern. Med. 163:205-9
7. Azevedo Da Silva M, Singh-Manoux A, Shipley MJ, Vahtera J, Brunner EJ, et al. 2014. Sleep duration and sleep disturbances partly explain the association between depressive symptoms and cardiovascular mortality: the Whitehall II cohort study. J. Sleep Res. 23:94-97
8. Baglioni C, Battagliese G, Feige B, Spiegelhalder K, Nissen C, et al. 2011. Insomnia as a predictor of depression: a meta-analytic evaluation of longitudinal epidemiological studies. J. Affect Disord. 135:10-19
9. Bauer J, Hohagen F, Gimmel E, Bruns F, Lis S, et al. 1995. Induction of cytokine synthesis and fever suppresses REM sleep and improves mood in patients with major depression. Biol. Psychiatry 38:611-21
10. Baune BT, Rothermundt M, Ladwig KH, Meisinger C, Berger K. 2011. Systemic inflammation (interleukin 6) predicts all-cause mortality in men: results from a 9-year follow-up of the MEMO study. Age (Dordr.) 33:209-17
11. Besedovsky L, Lange T, Born J. 2012. Sleep and immune function. Pflugers Arch. 463:121-37
12. Black DS, Cole SW, Irwin MR, Breen E, St Cyr NM, et al. 2013. Yogic meditation reverses NF-κB and IRF-related transcriptome dynamics in leukocytes of family dementia caregivers in a randomized controlled trial. Psychoneuroendocrinology 38:348-55
13. Bonnet MH, Arand DL. 1997. Hyperarousal and insomnia. Sleep Med. Rev. 1:97-108
14. Born J, Lange T, Hansen K, Molle M, Fehm HL. 1997. Effects of sleep and circadian rhythm on human circulating immune cells. J. Immunol. 158:4454-64
15. Boudreau P, Yeh WH, Dumont GA, Boivin DB. 2013. Circadian variation of heart rate variability across sleep stages. Sleep 36:1919-28
16. Brown R, Pang G, Husband AJ, King MG. 1989. Suppression of immunity to influenza virus infection in the respiratory tract following sleep disturbance. Reg. Immunol. 2:321-25
17. Burgos I, Richter L, Klein T, Fiebich B, Feige B, et al. 2006. Increased nocturnal interleukin-6 excretion in patients with primary insomnia: a pilot study. Brain Behav. Immun. 20:246-53
18. Buysse DJ. 2014. Sleep health: Can we define it? Does it matter? Sleep 37:9-17
19. Cappuccio FP, Cooper D, D'Elia L, Strazzullo P, Miller MA. 2011. Sleep duration predicts cardiovascular outcomes: a systematic review and meta-analysis of prospective studies. Eur. Heart J. 32:1484-92
20. Chennaoui M, Sauvet F, Drogou C, Van Beers P, Langrume C, et al. 2011. Effect of one night of sleep loss on changes in tumor necrosis factor alpha (TNF-α) levels in healthy men. Cytokine 56:318-24
21. Chien KL, Chen PC, Hsu HC, Su TC, Sung FC, et al. 2010. Habitual sleep duration and insomnia and the risk of cardiovascular events and all-cause death: report from a community-based cohort. Sleep 33:177-84
22. Chiu YL, Chuang YF, Fang KC, Liu SK, Chen HY, et al. 2009. Higher systemic inflammation is associated with poorer sleep quality in stable haemodialysis patients. Nephrol. Dial. Transpl. 24:247-51
23. Cho HJ, Lavretsky H, Olmstead R, Levin MJ, Oxman MN, Irwin MR. 2008. Sleep disturbance and depression recurrence in community-dwelling older adults: a prospective study. Am. J. Psychiatry 165:1543-50
24. Christian LM, Glaser R, Porter K, Malarkey WB, Beversdorf D, Kiecolt-Glaser JK. 2011. Poorer self-rated health is associated with elevated inflammatory markers among older adults. Psychoneuroendocrinology 36:1495-504
25. Chung WS, Lin CL, Chen YF, Chiang JY, Sung FC, et al. 2013. Sleep disorders and increased risk of subsequent acute coronary syndrome in individuals without sleep apnea: a nationwide population-based cohort study. Sleep 36:1963-68
26. Cohen S, Doyle WJ, Alper CM, Janicki-Deverts D, Turner RB. 2009. Sleep habits and susceptibility to the common cold. Arch. Intern. Med. 169:62-67
27. Cole JC, Motivala SJ, Buysse DJ, Oxman MN, Levin MJ, Irwin MR. 2006. Validation of a 3-factor scoring model for the Pittsburgh Sleep Quality Index in older adults. Sleep 29:112-16
28. Cole SW. 2009. Chronic inflammation and breast cancer recurrence. J. Clin. Oncol. 27:3418-19
29. Cole SW, Arevalo J, Takahashi R, Sloan EK, Lutgendorf S, et al. 2010. Computational identification of gene-social environment interaction at the human IL6 locus. Proc. Natl. Acad. Sci. USA 107:5681-86
30. Cole SW, Korin YD, Fahey JL, Zack JA. 1998. Norepinephrine accelerates HIV replication via protein kinase A-dependent effects on cytokine production. J. Immunol. 161:610-16
31. Conlon M, Lightfoot N, Kreiger N. 2007. Rotating shift work and risk of prostate cancer. Epidemiology 18:182-83
32. Cover H, Irwin M. 1994. Immunity and depression: insomnia, retardation, and reduction of natural killer cell activity. J. Behav. Med. 17:217-23
33. Creswell JD, Irwin MR, Burklund LJ, Lieberman MD, Arevalo JM, et al. 2012. Mindfulness-based stress reduction training reduces loneliness and pro-inflammatory gene expression in older adults: a small randomized controlled trial. Brain Behav. Immun. 26:1095-101
34. De Zambotti M, Covassin N, De Min Tona G, Sarlo M, Stegagno L. 2011. Sleep onset and cardiovascular activity in primary insomnia. J. Sleep Res. 20:318-25
35. Dew MA, Hoch CC, Buysse DJ, Monk TH, Begely AE, et al. 2003. Healthy older adults' sleep predicts all-cause mortality at 4 to 19 years of follow-up. Psychosom. Med. 65:63-73
36. Dimitrov S, Lange T, Benedict C, Nowell MA, Jones SA, et al. 2006. Sleep enhances IL-6 trans-signaling in humans. FASEB J. 20:2174-76
37. Dimitrov S, Lange T, Tieken S, Fehm HL, Born J. 2004. Sleep associated regulation of T helper 1/T helper 2 cytokine balance in humans. Brain Behav. Immun. 18:341-48
38. Dinges DF, Douglas SD, Hamarman S, Zaugg L, Kapoor S. 1995. Sleep deprivation and human immune function. Adv. Neuroimmunol. 5:97-110
39. Dinges DF, Douglas SD, Zaugg L, Campbell DE, McMann JM, et al. 1994. Leukocytosis and natural killer cell function parallel neurobehavioral fatigue induced by 64 hours of sleep deprivation. J. Clin. Investig. 93:1930-39
40. Dowd JB, Goldman N, Weinstein M. 2011. Sleep duration, sleep quality, and biomarkers of inflammation in a Taiwanese population. Ann. Epidemiol. 21:799-806
41. Dryman A, Eaton WW. 1991. Affective symptoms associated with the onset of major depression in the community: findings from the US National Institute of Mental Health Epidemiologic Catchment Area Program. Acta Psychiatr. Scand. 84:1-5
42. Eisenberger NI, Berkman ET, Inagaki TK, Rameson LT, Mashal NM, Irwin MR. 2010a. Inflammation-induced anhedonia: endotoxin reduces ventral striatum responses to reward. Biol. Psychiatry 68:748-54
43. Eisenberger NI, Inagaki TK, Mashal NM, Irwin MR. 2010b. Inflammation and social experience: an inflammatory challenge induces feelings of social disconnection in addition to depressed mood. Brain Behav. Immun. 24:558-63
44. Eisenberger NI, Inagaki TK, Rameson LT, Mashal NM, Irwin MR. 2009. An fMRI study of cytokine-induced depressed mood and social pain: the role of sex differences. Neuroimage 47:881-90
45. Erten Y, Kokturk O, Yuksel A, Elbeg S, Ciftci TU, et al. 2005. Relationship between sleep complaints and proinflammatory cytokines in haemodialysis patients. Nephrology (Carlton) 10:330-35
46. Esposito K, Pontillo A, Di Palo C, Giugliano G, Masella M, et al. 2003. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA 289:1799-804
47. Faraut B, Boudjeltia KZ, Dyzma M, Rousseau A, David E, et al. 2011. Benefits of napping and an extended duration of recovery sleep on alertness and immune cells after acute sleep restriction. Brain Behav. Immun. 25:16-24
48. Fernandez-Mendoza J, Vgontzas AN, Liao D, Shaffer ML, Vela-Bueno A, et al. 2012. Insomnia with objective short sleep duration and incident hypertension: the Penn State Cohort. Hypertension 60:929-35
49. Ford DE, Kamerow DB. 1989. Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention? JAMA 262:1479-84
50. Ford ES. 2002. Does exercise reduce inflammation? Physical activity and C-reactive protein among U. S. adults. Epidemiology 13:561-68
51. Frey DJ, Fleshner M, Wright KP Jr. 2007. The effects of 40 hours of total sleep deprivation on inflammatory markers in healthy young adults. Brain Behav. Immun. 21:1050-57
52. Friedman EM. 2005. Social relationships, sleep quality, and interleukin-6 in aging women. Proc. Natl. Acad. Sci. USA 102:18757-62
53. Friedman EM, Hayney MS, Love GD, Urry HL, Rosenkranz MA, et al. 2005. Social relationships, sleep quality, and interleukin-6 in aging women. Proc. Natl. Acad. Sci. USA 102:18757-62
54. Gangwisch JE, Malaspina D, Posner K, Babiss LA, Heymsfield SB, et al. 2010. Insomnia and sleep duration as mediators of the relationship between depression and hypertension incidence. Am. J. Hypertens. 23:62-69
55. Gimeno D, Kivimaki M, Brunner EJ, Elovainio M, De Vogli R, et al. 2009. Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II study. Psychol. Med. 39:413-23
56. Grandner MA, Perlis ML. 2013. Short sleep duration and insomnia associated with hypertension incidence. Hypertens. Res. 36:932-3
57. Haack M, Sanchez E, Mullington JM. 2007. Elevated inflammatory markers in response to prolonged sleep restriction are associated with increased pain experience in healthy volunteers. Sleep 30:1145-52
58. Haus EL, Smolensky MH. 2013. Shift work and cancer risk: potential mechanistic roles of circadian disruption, light at night, and sleep deprivation. Sleep Med. Rev. 17:273-84
59. Heslop P, Smith GD, Metcalfe C, Macleod J, Hart C. 2002. Sleep duration and mortality: the effect of short or long sleep duration on cardiovascular and all-cause mortality in working men and women. Sleep Med. 3:305-14
60. Hoevenaar-Blom MP, Spijkerman AM, Kromhout D, van den Berg JF, Verschuren WM. 2011. Sleep duration and sleep quality in relation to 12-year cardiovascular disease incidence: the MORGEN study. Sleep 34:1487-92
61. Ikehara S, Iso H, Date C, Kikuchi S, Watanabe Y, et al. 2009. Association of sleep duration with mortality from cardiovascular disease and other causes for Japanese men and women: the JACC study. Sleep 32:295-301
62. Imeri L, Opp MR. 2009. How (and why) the immune system makes us sleep. Nat. Rev. Neurosci. 10:199-210
63. Irwin M, Mascovich A, Gillin JC, Willoughby R, Pike J, Smith TL. 1994. Partial sleep deprivation reduces natural killer cell activity in humans. Psychosom. Med. 56: 493-98
64. Irwin M, McClintick J, Costlow C, Fortner M, White J, Gillin JC. 1996. Partial night sleep deprivation reduces natural killer and cellular immune responses in humans. FASEB J. 10: 643-53
65. Irwin M, Rinetti G, Redwine L, Motivala S, Dang J, Ehlers C. 2004. Nocturnal proinflammatory cytokine-associated sleep disturbances in abstinent African American alcoholics. Brain Behav. Immun. 18:349-60
66. Irwin M, Thompson J, Miller C, Gillin JC, Ziegler M. 1999. Effects of sleep and sleep deprivation on cate-cholamine and interleukin-2 levels in humans: clinical implications. J. Clin. Endocrinol. Metab. 84: 1979-85
67. Irwin MR, Carrillo C, Olmstead R. 2010. Sleep loss activates cellular markers of inflammation: sex differences. Brain Behav. Immun. 24:54-57
68. Irwin MR, Cole JC, Nicassio PM. 2006a. Comparative meta-analysis of behavioral interventions for insomnia and their efficacy in middle-aged adults and in older adults 55+ years of age. Health Psychol. 25:3-14
69. Irwin MR, Cole SW. 2011. Reciprocal regulation of the neural and innate immune systems. Nat. Rev. Immunol. 11:625-32
70. Irwin MR, Levin MJ, Laudenslager ML, Olmstead R, Lucko A, et al. 2013. Varicella zoster virus-specific immune responses to a herpes zoster vaccine in elderly recipients with major depression and the impact of antidepressant medications. Clin. Infect. Dis. 56:1085-93
71. Irwin MR, Miller AH. 2007. Depressive disorders and immunity: 20 years of progress and discovery. Brain Behav. Immun. 21:374-83
72. Irwin MR, Olmstead R. 2012. Mitigating cellular inflammation in older adults: a randomized controlled trial of tai chi chih. Am. J. Geriatr. Psychiatry 20:764-72
73. Irwin MR, Olmstead R, Carrillo C, Sadeghi N, Breen EC, et al. 2014. Cognitive behavioral therapy versus tai chi for late life insomnia and inflammation: a randomized controlled comparative efficacy trial. Sleep 37:1543-52
74. Irwin MR, Olmstead R, Motivala SJ. 2008a. Improving sleep quality in older adults with moderate sleep complaints: a randomized controlled trial of tai chi chih. Sleep 31:1001-8
75. Irwin MR, Olmstead R, Oxman MN. 2007. Augmenting immune responses to varicella zoster virus in older adults: a randomized, controlled trial of tai chi. J. Am. Geriatr. Soc. 55:511-17
76. Irwin MR, Olmstead R, Valladares EM, Breen EC, Ehlers CL. 2009. Tumor necrosis factor antagonism normalizes rapid eye movement sleep in alcohol dependence. Biol. Psychiatry 66:191-95
77. Irwin MR, Wang M, Campomayor CO, Collado-Hidalgo A, Cole S. 2006b. Sleep deprivation and activation of morning levels of cellular and genomic markers of inflammation. Arch. Intern. Med. 166:1756-62
78. Irwin MR, Wang M, Ribeiro D, Cho HJ, Olmstead R, et al. 2008b. Sleep loss activates cellular inflammatory signaling. Biol. Psychiatry 64:538-40
79. Irwin MR, Ziegler M. 2005. Sleep deprivation potentiates activation of cardiovascular and catecholamine responses in abstinent alcoholics. Hypertension 45: 252-57
80. Jaussent I, Bouyer J, Ancelin ML, Akbaraly T, Peres K, et al. 2011. Insomnia and daytime sleepiness are risk factors for depressive symptoms in the elderly. Sleep 34:1103-10
81. Jiao L, Duan Z, Sangi-Haghpeykar H, Hale L, White DL, El-Serag HB. 2013. Sleep duration and incidence of colorectal cancer in postmenopausal women. Br. J. Cancer 108:213-21
82. Joynt KE, Whellan DJ, O'Connor CM. 2003. Depression and cardiovascular disease: mechanisms of interaction. Biol. Psychiatry 54:248-61
83. Karin M. 2006. Nuclear factor-κB in cancer development and progression. Nature 441:431-36
84. Ko YJ, Kwon YM, Kim KH, Choi HC, Chun SH, et al. 2012. High-sensitivity C-reactive protein levels and cancer mortality. Cancer Epidemiol. Biomark. Prev. 21:2076-86
85. Kripke DF, Garfinkel L, Wingard DL, Klauber MR, Marler MR. 2002. Mortality associated with sleep duration and insomnia. Arch. Gen. Psychiatry 59:131-36
86. Kronfol Z, Nair M, Zhang Q, Hill EE, Brown MB. 1997. Circadian immune measures in healthy volunteers: relationship to hypothalamic-pituitary-adrenal axis hormones and sympathetic neurotransmitters. Psychosom. Med. 59:42-50
87. Kronholm E, Laatikainen T, Peltonen M, Sippola R, Partonen T. 2011. Self-reported sleep duration, all-cause mortality, cardiovascular mortality and morbidity in Finland. Sleep Med. 12:215-21
88. Kubo T, Oyama I, Nakamura T, Shirane K, Otsuka H, et al. 2011. Retrospective cohort study of the risk of obesity among shift workers: findings from the Industry-Based Shift Workers' Health study, Japan. Occup. Environ. Med. 68:327-31
89. Kubo T, Ozasa K, Mikami K, Wakai K, Fujino Y, et al. 2006. Prospective cohort study of the risk of prostate cancer among rotating-shift workers: findings from the Japan collaborative cohort study. Am. J. Epidemiol. 164:549-55
90. Lanfranchi PA, Pennestri MH, Fradette L, Dumont M, Morin CM, Montplaisir J. 2009. Nighttime blood pressure in normotensive subjects with chronic insomnia: implications for cardiovascular risk. Sleep 32:760-66
91. Lange T, Dimitrov S, Bollinger T, Diekelmann S, Born J. 2011. Sleep after vaccination boosts immunological memory. J. Immunol. 187:283-90
92. Lange T, Dimitrov S, Born J. 2010. Effects of sleep and circadian rhythm on the human immune system. Ann. N. Y. Acad. Sci. 1193:48-59
93. Lange T, Dimitrov S, Fehm HL, Born J. 2006a. Sleep-like concentrations of growth hormone and cortisol modulate type1 and type2 in-vitro cytokine production in human T cells. Int. Immunopharmacol. 6:216-25
94. Lange T, Dimitrov S, Fehm HL, Westermann J, Born J. 2006b. Shift of monocyte function toward cellular immunity during sleep. Arch. Intern. Med. 166:1695-700
95. Lange T, Marshall L, Spath-Schwalbe E, Fehm HL, Born J. 2002. Systemic immune parameters and sleep after ultra-low dose administration of IL-2 in healthy men. Brain Behav. Immun. 16:663-74
96. Lange T, Perras B, Fehm HL, Born J. 2003. Sleep enhances the human antibody response to hepatitis A vaccination. Psychosom. Med. 65:831-35
97. Larkin EK, Rosen CL, Kirchner HL, Storfer-Isser A, Emancipator JL, et al. 2005. Variation of C-reactive protein levels in adolescents: association with sleep-disordered breathing and sleep duration. Circulation 111:1978-84
98. Laugsand LE, Vatten LJ, Bjorngaard JH, Hveem K, Janszky I. 2012. Insomnia and high-sensitivity C-reactive protein: the HUNT study, Norway. Psychosom. Med. 74:543-53
99. LeBlanc M, Merette C, Savard J, Ivers H, Baillargeon L, Morin CM. 2009. Incidence and risk factors of insomnia in a population-based sample. Sleep 32:1027-37
100. Lee E, Cho HJ, Olmstead R, Levin MJ, Oxman MN, Irwin MR. 2013. Persistent sleep disturbance: a risk factor for recurrent depression in community-dwelling older adults. Sleep 36:1685-91
101. Lee JH, Kim SJ, Jung HH. 2009. Nocturnal sleep related with metabolic markers in end-stage renal disease patients receiving hemodialysis. Psychiatry Investig. 6:34-38
102. Libby P, Ridket PM, Maseri A. 2002. Inflammation and atherosclerosis. Circulation 105:1135-43
103. Lissoni P, Rovelli F, Brivio F, Brivio O, Fumagalli L. 1998. Circadian secretions of IL-2, IL-12, IL-6 and IL-10 in relation to the light/dark rhythm of the pineal hormone melatonin in healthy humans. Nat. Immun. 16:1-5
104. Littner M, Hirshkowitz M, Kramer M, Kapen S, Anderson WM, et al. 2003. Practice parameters for using polysomnography to evaluate insomnia: an update. Sleep 26:754-60
105. Liukkonen T, Rasanen P, Ruokonen A, Laitinen J, Jokelainen J, et al. 2007. C-reactive protein levels and sleep disturbances: observations based on the Northern Finland 1966 Birth Cohort study. Psychosom. Med. 69:756-61
106. Mallon L, Broman JE, Hetta J. 2002. Sleep complaints predict coronary artery disease mortality in males: a 12-year follow-up study of a middle-aged Swedish population. J. Intern. Med. 251:207-16
107. Manber R, Edinger JD, Gress JL, San Pedro-Salcedo MG, Kuo TF, Kalista T. 2008. Cognitive behavioral therapy for insomnia enhances depression outcome in patients with comorbid major depressive disorder and insomnia. Sleep 31:489-95
108. Mantovani A, Allavena P, Sica A, Balkwill F. 2008. Cancer-related inflammation. Nature 454:436-44
109. Marsland AL, Gianaros PJ, Abramowitch SM, Manuck SB, Hariri AR. 2008. Interleukin-6 covaries inversely with hippocampal grey matter volume in middle-aged adults. Biol. Psychiatry 64:484-90
110. Medzhitov R. 2008. Origin and physiological roles of inflammation. Nature 454:428-35
111. Meier-Ewert HK, Ridker PM, Rifai N, Regan MM, Price NJ, et al. 2004. Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. J. Am. Coll. Cardiol. 43:678-83
112. Meng L, Zheng Y, Hui R. 2013. The relationship of sleep duration and insomnia to risk of hypertension incidence: a meta-analysis of prospective cohort studies. Hypertens. Res. 36:985-95
113. Miller GE, Cohen S, Pressman S, Barkin A, Rabin BS, Treanor JJ. 2004. Psychological stress and antibody response to influenza vaccination: When is the critical period for stress, and how does it get inside the body? Psychosom. Med. 66:215-23
114. Miller MA, Kandala NB, Kivimaki M, Kumari M, Brunner EJ, et al. 2009. Gender differences in the cross-sectional relationships between sleep duration and markers of inflammation: Whitehall II study. Sleep 32:857-64
115. Moldofsky H, Lue FA, Davidson JR, Gorczynski R. 1989. Effects of sleep deprivation on human immune functions. FASEB J. 3:1972-77
116. Morin CM, Belanger L, LeBlanc M, Ivers H, Savard J, et al. 2009. The natural history of insomnia: a population-based 3-year longitudinal study. Arch. Intern. Med. 169:447-53
117. Morin CM, Belleville G, Belanger L, Ivers H. 2011. The insomnia severity index: psychometric indicators to detect insomnia cases and evaluate treatment response. Sleep 34:601-8
118. Morin CM, Bootzin RR, Buysse DJ, Edinger JD, Espie CA, Lichstein KL. 2006a. Psychological and behavioral treatment of insomnia: update of the recent evidence (1998-2004). Sleep 29:1398-414
119. Morin CM, LeBlanc M, Daley M, Gregoire JP, Merette C. 2006b. Epidemiology of insomnia: prevalence, self-help treatments, consultations, and determinants of help-seeking behaviors. Sleep Med. 7:123-30
120. Motivala S, Irwin MR. 2007. Sleep and immunity: cytokine pathways linking sleep and health outcomes. Curr. Dir. Psychol. Sci. 16:21-25
121. Mullington J, Korth C, Hermann DM, Orth A, Galanos C, et al. 2000. Dose-dependent effects of endotoxin on human sleep. Am. J. Physiol. Regul. Integr. Comp. Physiol. 278:R947-55
122. Mullington JM, Haack M, Toth M, Serrador JM, Meier-Ewert HK. 2009. Cardiovascular, inflammatory, and metabolic consequences of sleep deprivation. Prog. Cardiovasc. Dis. 51:294-302
123. Murphy K. 2011. Janeway's Immunobiology. New York: Garland Sci.
124. Murray DR, Irwin M, Rearden CA, Ziegler M, Motulsky H, Maisel AS. 1992. Sympathetic and immune interactions during dynamic exercise: mediation via beta 2-adrenergic-dependent mechanism. Circulation 83:203-13
125. Ohayon M. 1996. Epidemiological study on insomnia in the general population. Sleep 19:S7-15
126. Ohayon MM. 2002. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med. Rev. 6:97-111
127. Ohayon MM, Riemann D, Morin C, Reynolds CF 3rd. 2012. Hierarchy of insomnia criteria based on daytime consequences. Sleep Med. 13:52-57
128. Okun ML, Coussons-Read M, Hall M. 2009. Disturbed sleep is associated with increased C-reactive protein in young women. Brain Behav. Immun. 23:351-54
129. Okun ML, Coussons-Read ME. 2007. Sleep disruption during pregnancy: How does it influence serum cytokines? J. Reprod. Immunol. 73:158-65
130. Okun ML, Hall M, Coussons-Read ME. 2007. Sleep disturbances increase interleukin-6 production during pregnancy: implications for pregnancy complications. Reprod. Sci. 14:560-67
131. Palagini L, Bruno RM, Gemignani A, Baglioni C, Ghiadoni L, Riemann D. 2013. Sleep loss and hypertension: a systematic review. Curr. Pharm. Des. 19:2409-19
132. Parent ME, El-Zein M, Rousseau MC, Pintos J, Siemiatycki J. 2012. Night work and the risk of cancer among men. Am. J. Epidemiol. 176:751-59
133. Patel SR, Malhotra A, Gao X, Hu FB, Neuman MI, Fawzi WW. 2012. A prospective study of sleep duration and pneumonia risk in women. Sleep 35:97-101
134. Patel SR, Zhu X, Storfer-Isser A, Mehra R, Jenny NS, et al. 2009. Sleep duration and biomarkers of inflammation. Sleep 32:200-4
135. Petrovsky N, Harrison LC. 1997. Diurnal rhythmicity of human cytokine production. J. Immunol. 158:5163-68
136. Petrovsky N, McNair P, Harrison LC. 1998. Diurnal rhythms of pro-inflammatory cytokines: regulation by plasma cortisol and therapeutic implications. Cytokine 10:307-12
137. Phillips B, Bu°zková P, Enright P, Cardiovasc. Health Study Res. Group. 2009. Insomnia did not predict incident hypertension in older adults in the cardiovascular health study. Sleep 32:65-72
138. Phillips B, Mannino DM. 2007. Do insomnia complaints cause hypertension or cardiovascular disease? J. Clin. Sleep Med. 3:489-94
139. Pierce BL, Ballard-Barbash R, Bernstein L, Baumgartner RN, Neuhouser ML, et al. 2009. Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients. J. Clin. Oncol. 27:3437-44
140. Pollmacher T, Schuld A, Kraus T, Haack M, Hinze-Selch D, Mullington J. 2000. Experimental immunomod-ulation, sleep, and sleepiness in humans. Ann. N. Y. Acad. Sci. 917:488-99
141. Prather AA, Hall M, Fury JM, Ross DC, Muldoon MF, et al. 2012. Sleep and antibody response to hepatitis B vaccination. Sleep 35:1063-69
142. Pressman SD, Cohen S, Miller GE, Barkin A, Rabin BS, Treanor JJ. 2005. Loneliness, social network size, and immune response to influenza vaccination in college freshmen. Health Psychol. 24:297-306
143. Raison CL, Rutherford RE, Woolwine BJ, Shuo C, Schettler P, et al. 2013. A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiatry 70:31-41
144. Raison CL, Rye DB, Woolwine BJ, Vogt GJ, Bautista BM, et al. 2010. Chronic interferon-alpha administration disrupts sleep continuity and depth in patients with hepatitis C: association with fatigue, motor slowing, and increased evening cortisol. Biol. Psychiatry 68:942-49
145. Ramey SL, Perkhounkova Y, Moon M, Budde L, Tseng HC, Clark MK. 2012. The effect of work shift and sleep duration on various aspects of police officers' health. Workplace Health Saf. 60:215-22
146. Razeghi E, Sahraian MA, Heidari R, Bagherzadeh M. 2012. Association of inflammatory biomarkers with sleep disorders in hemodialysis patients. Acta Neurol. Belg. 112:45-49
147. Redwine L, Dang J, Hall M, Irwin M. 2003. Disordered sleep, nocturnal cytokines, and immunity inalcoholics. Psychosom. Med. 65:75-85
148. Redwine L, Hauger RL, Gillin JC, Irwin M. 2000. Effects of sleep and sleep deprivation on interleukin-6, growth hormone, cortisol, and melatonin levels in humans. J. Clin. Endocrinol. Metab. 85:3597-603
149. Reid S, Dwyer J. 2005. Insomnia in HIV infection: a systematic review of prevalence, correlates, and management. Psychosom. Med. 67:260-69
150. Renegar KB, Crouse D, Floyd RA, Krueger J. 2000. Progression of influenza viral infection through the murine respiratory tract: the protective role of sleep deprivation. Sleep 23:859-63
151. Renegar KB, Floyd R, Krueger JM. 1998a. Effect of sleep deprivation on serum influenza-specific IgG. Sleep 21:19-24
152. Renegar KB, Floyd RA, Krueger JM. 1998b. Effects of short-term sleep deprivation on murine immunity to influenza virus in young adult and senescent mice. Sleep 21:241-48
153. Rief W, Mills PJ, Ancoli-Israel S, Ziegler MG, Pung MA, Dimsdale JE. 2010. Overnight changes of immune parameters and catecholamines are associated with mood and stress. Psychosom. Med. 72:755-62
154. Riemann D. 2010. Hyperarousal and insomnia: state of the science. Sleep Med. Rev. 14:17
155. Sabanayagam C, Shankar A, Buchwald D, Goins RT. 2011. Insomnia symptoms and cardiovascular disease among older American Indians: the Native Elder Care Study. J. Environ. Public Health 2011:964617
156. Satoh M, Shimoda Y, Maesawa C, Akatsu T, Ishikawa Y, et al. 2005. Activated toll-like receptor 4 in monocytes is associated with heart failure after acute myocardial infarction. Int. J. Cardiol. 109:226-34
157. Sauvet F, Leftheriotis G, Gomez-Merino D, Langrume C, Drogou C, et al. 2010. Effect of acute sleep deprivation on vascular function in healthy subjects. J. Appl. Physiol. 108:68-75
158. Savard J, Laroche L, Simard S, Ivers H, Morin CM. 2003. Chronic insomnia and immune functioning. Psychosom. Med. 65:211-21
159. Schmid SM, Hallschmid M, Jauch-Chara K, Wilms B, Lehnert H, et al. 2011. Disturbed glucoregulatory response to food intake after moderate sleep restriction. Sleep 34:371-77
160. Schwartzbaum J, Ahlbom A, Feychting M. 2007. Cohort study of cancer risk among male and female shift workers. Scand. J. Work Environ. Health 33:336-43
161. Shearer WT, Reuben JM, Mullington JM, Price NJ, Lee BN, et al. 2001. Soluble TNF-αreceptor 1 and IL-6 plasma levels in humans subjected to the sleep deprivation model of spaceflight. J. Allergy Clin. Immunol. 107:165-70
162. Shiels MS, Pfeiffer RM, Hildesheim A, Engels EA, Kemp TJ, et al. 2013. Circulating inflammation markers and prospective risk for lung cancer. J. Natl. Cancer Inst. 105:1871-80
163. Siemes C, Visser LE, Coebergh JW, Splinter TA, Witteman JC, et al. 2006. C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam Study. J. Clin. Oncol. 24:5216-22
164. Sigurdardottir LG, Valdimarsdottir UA, Mucci LA, Fall K, Rider JR, et al. 2013. Sleep disruption among older men and risk of prostate cancer. Cancer Epidemiol. Biomark. Prev. 22:872-79
165. Slavich GM, Irwin MR. 2014. From stress to inflammation and major depressive disorder: a social signal transduction theory of depression. Psychol. Bull. 140:774-815
166. Somers VK, Dyken ME, Mark AL, Abboud FM. 1993. Sympathetic-nerve activity during sleep in normal subjects. N. Engl. J. Med. 328:303-7
167. Spath-Schwalbe E, Hansen K, Schmidt F, Schrezenmeier H, Marshall L, et al. 1998. Acute effects of recom-binant human interleukin-6 on endocrine and central nervous sleep functions in healthy men. J. Clin. Endocrinol. Metab. 83:1573-79
168. Spath-Schwalbe E, Lange T, Perras B, Fehm HL, Born J. 2000. Interferon-αacutely impairs sleep in healthy humans. Cytokine 12:518-21
169. Spiegel K, Sheridan JF, Van Cauter E. 2002. Effect of sleep deprivation on response to immunization. JAMA 288:1471-72
170. Stamatakis KA, Punjabi NM. 2010. Effects of sleep fragmentation on glucose metabolism in normal subjects. Chest 137:95-101
171. Stenholm S, Kronholm E, Bandinelli S, Guralnik JM, Ferrucci L. 2011. Self-reported sleep duration and time in bed as predictors of physical function decline: results from the InCHIANTI study. Sleep 34:1583-93
172. Suarez EC. 2008. Self-reported symptoms of sleep disturbance and inflammation, coagulation, insulin resistance and psychosocial distress: evidence for gender disparity. Brain Behav. Immun. 22:960-68
173. Suka M, Yoshida K, Sugimori H. 2003. Persistent insomnia is a predictor of hypertension in Japanese male workers. J. Occup. Health 45:344-50
174. Suzuki E, Yorifuji T, Ueshima K, Takao S, Sugiyama M, et al. 2009. Sleep duration, sleep quality and cardiovascular disease mortality among the elderly: a population-based cohort study. Prev. Med. 49:135-41
175. Taheri S, Austin D, Lin L, Nieto FJ, Young T, Mignot E. 2007. Correlates of serum C-reactive protein (CRP)-no association with sleep duration or sleep disordered breathing. Sleep 30:991-96
176. Taveras EM, Rifas-Shiman SL, Rich-Edwards JW, Mantzoros CS. 2011. Maternal short sleep duration is associated with increased levels of inflammatory markers at 3 years postpartum. Metabolism 60:982-86
177. Toth LA. 1995. Sleep, sleep deprivation and infectious disease: studies in animals. Adv. Neuroimmunol. 5:79-92
178. Touvier M, Fezeu L, Ahluwalia N, Julia C, Charnaux N, et al. 2013. Association between prediagnostic biomarkers of inflammation and endothelial function and cancer risk: a nested case-control study. Am. J. Epidemiol. 177:3-13
179. Tyring S, Gottlieb A, Papp K, Gordon K, Leonardi C, et al. 2006. Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. Lancet 367:29-35
180. van Leeuwen WMA, Lehto M, Karisola P, Lindholm H, Luukkonen R, et al. 2009. Sleep restriction increases the risk of developing cardiovascular diseases by augmenting proinflammatory responses through IL-17 and CRP. PLOS ONE 4:e4589
181. van Mark A, Weiler SW, Schröder M, Otto A, Jauch-Chara K, et al. 2010. The impact of shift work induced chronic circadian disruption on IL-6 and TNF-αimmune responses. J. Occup. Med. Toxicol. 5:18
182. Vgontzas AN, Fernandez-Mendoza J, Liao D, Bixler EO. 2013. Insomnia with objective short sleep duration: the most biologically severe phenotype of the disorder. Sleep Med. Rev. 17:241-54
183. Vgontzas AN, Liao D, Bixler EO, Chrousos GP, Vela-Bueno A. 2009. Insomnia with objective short sleep duration is associated with a high risk for hypertension. Sleep 32:491-97
184. Vgontzas AN, Papanicolaou DA, Bixler EO, Lotsikas A, Zachman K, et al. 1999. Circadian interleukin-6 secretion and quantity and depth of sleep. J. Clin. Endocrinol. Metab. 84:2603-7
185. Vgontzas AN, Pejovic S, Zoumakis E, Lin HM, Bixler EO, et al. 2007. Daytime napping after a night of sleep loss decreases sleepiness, improves performance, and causes beneficial changes in cortisol and interleukin-6 secretion. Am. J. Physiol. Endocrinol. Metab. 292:E253-61
186. Vgontzas AN, Zoumakis E, Bixler EO, Lin HM, Follett H, et al. 2004a. Adverse effects of modest sleep restriction on sleepiness, performance, and inflammatory cytokines. J. Clin. Endocrinol. Metab. 89:2119-26
187. Vgontzas AN, Zoumakis E, Lin HM, Bixler EO, Trakada G, Chrousos GP. 2004b. Marked decrease in sleepiness in patients with sleep apnea by etanercept, a tumor necrosis factor-α antagonist. J. Clin. Endocrinol. Metab. 89:4409-13
188. Vgontzas AN, Zoumakis M, Papanicolaou DA, Bixler EO, Prolo P, et al. 2002. Chronic insomnia is associated with a shift of interleukin-6 and tumor necrosis factor secretion from nighttime to daytime. Metabolism 51:887-92
189. Vogtmann E, Levitan EB, Hale L, Shikany JM, Shah NA, et al. 2013. Association between sleep and breast cancer incidence among postmenopausal women in the women's health initiative. Sleep 36:1437-44
190. von Ruesten A, Weikert C, Fietze I, Boeing H. 2012. Association of sleep duration with chronic diseases in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study. PLOS ONE 7:e30972
191. Vozoris NT. 2013. The relationship between insomnia symptoms and hypertension using United States population-level data. J. Hypertens. 31:663-71
192. Wang Q, Xi B, Liu M, Zhang Y, Fu M. 2012. Short sleep duration is associated with hypertension risk among adults: a systematic review and meta-analysis. Hypertens. Res. 35:1012-18
193. Youngstedt SD, Kripke DF. 2004. Long sleep and mortality: rationale for sleep restriction. Sleep Med. Rev. 8:159-74
194. Zamarron F, Maceiras F, Mera A, Gomez-Reino JJ. 2004. Effects of the first infliximab infusion on sleep and alertness in patients with active rheumatoid arthritis. Ann. Rheum. Dis. 63:88-90
195. Zautra AJ, Davis MC, Reich JW, Nicassio P, Tennen H, et al. 2008. Comparison of cognitive behavioral and mindfulness meditation interventions on adaptation to rheumatoid arthritis for patients with and without history of recurrent depression. J. Consult. Clin. Psychol. 76:408-21
196. Zhang J, Lamers F, Hickie IB, He JP, Feig E, Merikangas KR. 2013a. Differentiating nonrestorative sleep from nocturnal insomnia symptoms: demographic, clinical, inflammatory, and functional correlates. Sleep 36:671-79
197. Zhang X, Giovannucci EL, Wu K, Gao X, Hu F, et al. 2013b. Associations of self-reported sleep duration and snoring with colorectal cancer risk in men and women. Sleep 36:681-88